IN2014CH01141A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CH01141A IN2014CH01141A IN1141CH2014A IN2014CH01141A IN 2014CH01141 A IN2014CH01141 A IN 2014CH01141A IN 1141CH2014 A IN1141CH2014 A IN 1141CH2014A IN 2014CH01141 A IN2014CH01141 A IN 2014CH01141A
- Authority
- IN
- India
- Prior art keywords
- glucitol
- anhydro
- ethoxyphenyl
- chloro
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2015/000119 WO2015132803A2 (en) | 2014-03-06 | 2015-03-06 | Process for the preparation of (1s)-1,5-anhydro-1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-d-glucitol and its solvate thereof |
EP15758707.2A EP3114115A4 (en) | 2014-03-06 | 2015-03-06 | Process for the preparation of (1s)-1,5-anhydro-1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-d-glucitol and its solvate thereof |
US15/303,577 US20170029398A1 (en) | 2014-03-06 | 2015-03-06 | Process for the preparation of (1s)-1,5-anhydro-1-c-{4-chloro-3-4[(4-ethoxyphenyl)methyl]phenyl]-glucitol and its solvate thereof |
IN1141CH2014 IN2014CH01141A (uk) | 2014-03-06 | 2015-03-06 | |
US16/202,840 US20190144411A1 (en) | 2014-03-06 | 2018-11-28 | Process for the preparation of (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl) methyl]phenyl]-D-glucitol and its solvate thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1141CH2014 IN2014CH01141A (uk) | 2014-03-06 | 2015-03-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CH01141A true IN2014CH01141A (uk) | 2015-09-11 |
Family
ID=54055961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1141CH2014 IN2014CH01141A (uk) | 2014-03-06 | 2015-03-06 |
Country Status (4)
Country | Link |
---|---|
US (2) | US20170029398A1 (uk) |
EP (1) | EP3114115A4 (uk) |
IN (1) | IN2014CH01141A (uk) |
WO (1) | WO2015132803A2 (uk) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106316803B (zh) * | 2015-06-19 | 2019-07-09 | 重庆博腾制药科技股份有限公司 | 一种sglt-2抑制剂中间体的合成方法 |
US10428053B2 (en) | 2015-09-15 | 2019-10-01 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
US9845303B2 (en) | 2015-10-19 | 2017-12-19 | Cadila Healthcare Limited | Process for the preparation of dapagliflozin |
US10913762B2 (en) | 2016-01-27 | 2021-02-09 | Msn Laboratories Private Limited | Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof |
WO2017221211A1 (en) * | 2016-06-24 | 2017-12-28 | Biocon Limited | Process for the preparation of dapagliflozin and its solvate thereof |
CN107641139A (zh) * | 2016-07-22 | 2018-01-30 | 江苏豪森药业集团有限公司 | 达格列净中间体的晶型及其制备方法 |
CN108610316B (zh) * | 2016-12-09 | 2021-11-05 | 江苏豪森药业集团有限公司 | 达格列净的制备方法 |
WO2018142422A1 (en) * | 2017-02-02 | 2018-08-09 | Indoco Remedies Limited | Process for the preparation of dapagliflozin |
CN107417515A (zh) * | 2017-03-30 | 2017-12-01 | 上海常丰生物医药科技有限公司 | 一种合成达格列净中间体的新方法 |
CN109705075B (zh) * | 2018-12-13 | 2022-12-23 | 苏中药业集团股份有限公司 | 一种达格列净的纯化方法 |
CN110396040B (zh) * | 2019-09-09 | 2020-12-15 | 东南大学 | 一种一锅法合成二芳基甲缩酮的方法 |
WO2021176096A1 (en) | 2020-03-05 | 2021-09-10 | Krka, D.D., Novo Mesto | Pharmaceutical composition comprising sglt2 inhibitor |
CN115867538A (zh) | 2020-06-05 | 2023-03-28 | 新梅斯托克公司 | 高纯的无定形达格列净的制备 |
CN111748004A (zh) * | 2020-06-30 | 2020-10-09 | 药璞(上海)医药科技有限公司 | 一种高纯度达格列净中间体的晶型及其制备方法 |
CN112500267A (zh) | 2020-12-04 | 2021-03-16 | 江苏慧聚药业有限公司 | 4-溴-2-(4’-乙氧基-苄基)-1-氯苯的制备 |
CN113880796A (zh) * | 2021-10-14 | 2022-01-04 | 山东诚创蓝海医药科技有限公司 | 一种达格列净的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515117B2 (en) * | 1999-10-12 | 2003-02-04 | Bristol-Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
PH12000002657B1 (en) * | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
CN101260130A (zh) * | 2003-01-03 | 2008-09-10 | 布里斯托尔-迈尔斯斯奎布公司 | 制备c-芳基葡糖苷sglt2抑制剂的方法 |
US7919598B2 (en) * | 2006-06-28 | 2011-04-05 | Bristol-Myers Squibb Company | Crystal structures of SGLT2 inhibitors and processes for preparing same |
KR101604119B1 (ko) * | 2011-06-14 | 2016-03-16 | 주식회사 녹십자 | 신규한 c-아릴 안사 sglt2 억제제 |
CN103889429B (zh) * | 2011-10-31 | 2016-10-19 | 台湾神隆股份有限公司 | Sglt2抑制剂的结晶和非结晶形式 |
WO2015104658A2 (en) * | 2014-01-08 | 2015-07-16 | Dr. Reddy’S Laboratories Limited | Amorphous solid dispersion of dapagliflozin and process for the preparation of amorphous dapagliflozin |
-
2015
- 2015-03-06 US US15/303,577 patent/US20170029398A1/en not_active Abandoned
- 2015-03-06 EP EP15758707.2A patent/EP3114115A4/en not_active Withdrawn
- 2015-03-06 WO PCT/IN2015/000119 patent/WO2015132803A2/en active Application Filing
- 2015-03-06 IN IN1141CH2014 patent/IN2014CH01141A/en unknown
-
2018
- 2018-11-28 US US16/202,840 patent/US20190144411A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20190144411A1 (en) | 2019-05-16 |
WO2015132803A2 (en) | 2015-09-11 |
US20170029398A1 (en) | 2017-02-02 |
WO2015132803A3 (en) | 2016-01-14 |
EP3114115A2 (en) | 2017-01-11 |
EP3114115A4 (en) | 2017-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014CH01141A (uk) | ||
MX2017004200A (es) | Compuestos de heteroarilo como inhibidores de tirosina-cinasa de bruton (btk) y usos de estos. | |
EP3209653A4 (en) | Process for the preparation of (r,s)-nicotine | |
IN2014CH00247A (uk) | ||
EP3137074A4 (en) | Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto | |
EA201691648A1 (ru) | Способ получения противогрибковых соединений | |
EA201691649A1 (ru) | Способ получения противогрибковых соединений | |
IL250038A0 (en) | 4,5 - dehydroisoxazole derivatives used as nampt inhibitors | |
EP3102554A4 (en) | Conversion of 2,3-butanediol to butadiene | |
CL2017000152A1 (es) | Derivados de isoindolinona | |
EA201790982A1 (ru) | Синтез копанлисиба и его дигидрохлорида | |
PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
EP3449001A4 (en) | INHIBITION OF ARNMI MIR-22 BY APT-110 | |
CL2017000151A1 (es) | Derivados de piridona | |
MX2016015464A (es) | Composicion farmaceutica oral de isotretinoina. | |
IN2014MU01192A (uk) | ||
MX2016015465A (es) | Composicion farmaceutica oral de isotretinoina. | |
IN2014MU00195A (uk) | ||
IN2014CH00304A (uk) | ||
EP3102540A4 (en) | Compositions including a vacancy-engineered (ve)-zno nanocomposite, methods of making a composition, methods of using a composition | |
EA201692246A1 (ru) | Способ получения 2,6-диметилбензохинона | |
MX2017001331A (es) | Composicion farmaceutica oral de isotretinoina. | |
EP3162789A4 (en) | Production intermediate of polymerizable compound, method for producing same, composition and stabilization method | |
GB2564185A (en) | Process for the preparation of derivatives of benzodioxole | |
IN2014MU00194A (uk) |